Exciting times for #colorectal surgical oncology collaboration in South Australia. Great morning meeting with the excellent Flinders University colorectal MDT team. Thank you Tiong Cheng Sia for hosting and the warm welcome!

We’re excited to share an update on what’s in store for the Tripartite Colorectal Meeting this September! Hear directly from our Programme Committee Chair, Quentin Denost, as he shares what you can look forward to. #ColorectalSurgery #Tripartite2025 #MedicalConference

Australia records highest rates of early onset bowel cancer in the world abc.net.au/listen/program… via ABC Australia

Excited to report that the EARLY-TNT trial is officially open! Congrats Zachary Bunjo for getting this pioneering study going. Working through ethics at all sites now, so if you are a colorectal unit in ANZ interested in participating, please contact us. anzctr.org.au/Trial/Registra…

Total Neoadjuvant Therapy adoption in ANZ from CSSANZ registry data. A significant increase from 11% in 2018 to 41% in 2023! onlinelibrary.wiley.com/doi/10.1111/an…

📢 Looking forward to the #BJSAward? With only a few days remaining, take a look back on 2023's winner 'A surgical life by Henrik Kehlet' ➡️ bjsacademy.com/bjs-academy/su… Who do you think will win the 2025 BJS Award? 📺 BJS Award Ceremony streaming LIVE from LONDON Friday 13 June

It's amazing how often ideas materialise on the "back of a napkin". The EARLY-TNT Trial

Great morning at Burnside Library delivering a Bowel Cancer information session. Thanks to everyone who came along and to the library team for hosting!#BowelCancerAwareness

The The EARLY-TNT Trial trial has recruited its first patients Central Adelaide! 🥳 We are in the final stages of local governance clearance across the rest of SA, with additional applications underway at sites around ANZ! If you’re an interested colorectal unit in ANZ, get in touch! 😃

Featured: The Landmark Series: Neoadjuvant Therapy for Locally Advanced #RectalCancer Zachary Bunjo Tarik Sammour ow.ly/ToSM50WhuPK @jeffreyfarma Syed A. Ahmad

📣 Applications are now open for the 2025 CSSANZ Nurses Award! This award celebrates registered nurses in Australia and New Zealand who excel in colorectal care, offering recognition in two categories: Professional Excellence and Publications & Educational Materials.

Great paper by RAH Colorectal Research Group 🫐 stoma nurse, Amy Foreman. DBUC's are a relatively new stoma configuration but becoming more common in exenteration surgery. Ongoing work here is extremely helpful for us as surgeons, and for the patients who manage these. search.informit.org/doi/10.3316/in…

Medical bill after an overnight stay in 🇺🇸 - is this even real?

July Issue: Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic #ColorectalCancer Kadhim Taqi rdcu.be/exRgz Casey J Allen, MD Syed A. Ahmad

Join Dr. Tarik Sammour at this year’s Tripartite Medical Conference in Paris, where he will explore funding models and challenges within the current healthcare monetary system. Dr. Sammour will also discuss potential solutions for achieving sustainable and adequate funding. 🗓

JUST ONE MONTH TO GO!

📣 Join us at #Tripartite2025 in Paris, Sept 10–12! 🌍 Global meeting of colorectal experts featuring ASCRS_1 @ACPGBI CSSANZ European Society of Coloproctology RACSurgeons RSM Coloproctology Section We look forward to seeing you! cssanz.org/Web/Web/Events… #ColorectalSurgery #Paris2025

#DCRJournal visual abstract | Effectiveness of Organ Preservation for Locally Advanced Rectal Cancer With Complete Clinical Response After Neoadjuvant Chemoradiotherapy: Bayesian Network Meta-analysis: bit.ly/43iRXWg Nell Maloney Patel Avery Walker, MD, FACS, FASCRS

Featured: Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced #ColonCancer : A Systematic Review, Meta-Analysis, and Sequential Analysis. Richard Sassun M.D. ow.ly/NWam50WCgAN @csabagajdos1 Syed A. Ahmad

Wow. If it makes this much difference in locally advanced colon cancer, imagine the potential survival advantage in node positive and resectable stage IV colon cancer. Eric J. Dozois David Larson, MD MBA